Researchers have made an important step forward toward a long-desired goal: using the gene-editing technology CRISPR to treat cancer. In a study published in Nature, scientists recruited 16 people who ...
Longfin smelt can be difficult to differentiate from endangered Delta smelt. Here, a longfin smelt is swabbed for genetic identification through a CRISPR tool called SHERLOCK. (Alisha Goodbla/UC Davis ...
CRISPR technology may soon lead to major stock growth in genomics. CRISPR therapies target diseases with genetic editing either inside or outside the body. Beam, CRISPR Therapeutics, Caribou, and ...
CRISPR has the power to correct genetic mutations, but current delivery methods are either unsafe or inefficient, keeping the technology from reaching its full medical potential. With the power to ...
The practice of genetic modification is as old as humanity. For thousands of years, humans have bred crops, livestock and even pets that possess desirable traits. This selective process, which alters ...
Two women have won the Nobel prize in chemistry for the development of a revolutionary gene editing tool that’s been described as “rewriting the code of life.” The technique discovered by Emmanuelle ...
Several ETFs focus on CRISPR gene editing, including ARKG and GNOM. ARKG owns shares in companies developing CRISPR therapies such as CRISPR Therapeutics. WDNA tracks companies transformed by genetics ...
Vertex is severing one of its ties to CRISPR Therapeutics. The big biotech has chosen to opt out of the diabetes gene-edited stem cell therapy it gained through the acquisition of ViaCyte, leaving ...
Ermias Kebreab, left, and Matthias Hess, right, with the College of Agricultural and Environmental Sciences, will work with UC collaborators to cut methane emissions from cow guts using the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback